0 items USD 0.00Search
- Did you mean
- global intravenous thrombosis (vte)
Your search for "Global Venous thromboembolism (VTE)" gave back 83352 results.
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Rivaroxaban market size was valued at USD 8226.5 million in 2023 and is forecast to a readjusted size of USD 13960 million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Rivaroxaban market size was valued at US$ 7821.1 million in 2023. With growing demand in downstream market, the Rivaroxaban is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Summary The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin ], enoxaparin [Lovenox ]) and factor Xa...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Summary The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin ], enoxaparin [Lovenox ]) and factor Xa...
Catalog:
HYR
June 2022
Price: USD 1,800.00
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Injectable Anticoagulants market size was valued at USD 6268.4 million in 2023 and is forecast to a readjusted size of USD 7205.2 million...
Catalog:
GIR
January 2024
Price: USD 3,480.00
